New evidence for flexible psilocybin dosing in patients with treatment-resistant depression
No abstract is available for this record.
Bibliographic context
Topics and keywords
psilocybin DepressionPharmacologyTreatment-Resistant Depression Other PsilocybinDosingTreatment-resistant depressionDepression (economics)PsychiatryMedicinePsychologyHallucinogenPharmacologyMajor depressive disorderCognitionEconomicsMacroeconomicsPsychedelics and Drug StudiesChemical synthesis and alkaloidsBody Image and Dysmorphia Studies
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
The Potential of Psilocybin Administration in Terminal Cancer PatientsOncology Times · 2019-06-27Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effectsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-02-11The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-24Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2019-12-31The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-07-31Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-12Can Psilocybin Treat Severe DepressionJournal watch · 2017-11-02Psilocybin to Manage Cancer-Related DepressionUnknown journal · 2016-12-20